Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Pyxis Oncology Inc (PYXS)

Pyxis Oncology Inc (PYXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
This Natural Killer Treatment Could Help Transform How Cancer is Treated BayStreet.ca - Mon May 19, 10:09AM CDT

GT Biopharma (NASDAQ: GTBP) just initiated the dosing in Cohort 2 of its Phase 1 dose escalation trial evaluating GTB-3650 for the treatment of relapsed or refractory (r/r) CD33 expressing hematologic...

PYXS : 1.1700 (+2.63%)
IOVA : 1.9800 (-2.94%)
BTAI : 1.6000 (-7.51%)
GTBP : 3.05 (+3.74%)
FATE : 1.1900 (-1.65%)
Pyxis Oncology Reports First Quarter 2025 Financial Results and Provides Business Update GlobeNewswire - Thu May 15, 6:00AM CDT

PYXS : 1.1700 (+2.63%)
Pyxis Oncology to Participate in Two Upcoming Investor Conferences GlobeNewswire - Wed May 14, 6:30AM CDT

PYXS : 1.1700 (+2.63%)
New Approaches to Tumor Targeting Are Driving the Next Wave of Oncology Breakthroughs BayStreet.ca - Wed May 7, 9:05AM CDT

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – Baystreet.ca News Commentary – Innovation in biotech is rapidly reshaping how we fight cancer, a trend reflected in the upcoming European...

PYXS : 1.1700 (+2.63%)
BVAXF : 0.0274 (-7.12%)
BIOV.CN : 0.0400 (+14.29%)
SONA.CN : 0.4300 (+8.86%)
GRAL : 45.63 (-5.80%)
SNANF : 0.3085 (+3.18%)
ADPT : 10.38 (-0.86%)
Pyxis Oncology Presents Promising Preclinical Results Providing Proof of Mechanism of Micvotabart Pelidotin, the First-in-Concept Extracellular-Targeting ADC GlobeNewswire - Fri Apr 25, 12:17PM CDT

PYXS : 1.1700 (+2.63%)
Zacks Industry Outlook Highlights Aurinia Pharmaceuticals, Heron Therapeutics, Esperion Therapeutics, Pyxis Oncology and Plus Therapeutics
Zacks Industry Outlook Highlights Aurinia Pharmaceuticals, Heron Therapeutics, Esperion Therapeutics, Pyxis Oncology and Plus Therapeutics Zacks Investment Research - Thu Apr 24, 1:36PM CDT

For Immediate ReleaseChicago, IL – April 24, 2025 – Today, Zacks Equity Research discusses Aurinia Pharmaceuticals AUPH, Heron Therapeutics HRTX, Esperion Therapeutics ESPR, Pyxis Oncology PYXS and...

ESPR : 1.0700 (-2.73%)
PSTV : 0.1940 (-4.20%)
PYXS : 1.1700 (+2.63%)
AUPH : 7.77 (-1.89%)
HRTX : 2.00 (unch)
Pyxis Oncology to Participate in the Stifel 2025 Virtual Targeted Oncology Forum GlobeNewswire - Wed Apr 2, 6:30AM CDT

PYXS : 1.1700 (+2.63%)
Pyxis Oncology to Present New Preclinical Data Supporting Development of First-In-Concept ADC Targeting EDB+FN in Tumor Microenvironment at AACR 2025 GlobeNewswire - Tue Mar 25, 3:30PM CDT

PYXS : 1.1700 (+2.63%)
Pyxis Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update GlobeNewswire - Tue Mar 18, 6:30AM CDT

PYXS : 1.1700 (+2.63%)
Pyxis Oncology to Participate at the Leerink Partners Global Healthcare Conference GlobeNewswire - Mon Mar 3, 6:30AM CST

PYXS : 1.1700 (+2.63%)

Barchart Exclusives

AMD Is Gunning for Nvidia’s AI Chip Throne. Should You Buy AMD Stock Now? Barchart - Sat Jun 21, 12:00PM CDT
The Instinct MI400 chips have brought AMD within striking distance of Nvidia’s AI dominance. Is it time to ride that momentum? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot